|
This communication is intended for internal distribution only and should not be shared with the general public.
After a careful analysis of the pending impact of the Inflation Reduction Act on Medicare Prescription Drug Plans (PDPs), Mutual of Omaha Rx has made the strategic decision to exit the Medicare Prescription Drug Plan market at the end of 2024. As a leading provider of Medicare supplement insurance for more than 50 years, we remain fully committed to offering valuable solutions to senior health customers, including Medicare supplement, dental and vision coverage, as well as our co-branded Medicare Advantage PPO plans with Wellcare.
We are also discontinuing marketing of our Mutual of Omaha Rx Prescription Drug Plans, effective immediately to prevent further customer disruption. Consumer marketing materials will no longer be available in Forms and Materials as of today, however Mutual of Omaha Rx enrollment kits will be available and accepted until further notice.
For more information, please review the Frequently Asked Questions (FAQ). We will continue to update the FAQs document, as needed.
We remain committed to offering a variety of valuable solutions to senior health customers, including Medicare supplement, dental and vision coverage, as well as our new co-branded Medicare Advantage PPO plans with Wellcare. We appreciate you trusting us with your business and look forward to helping grow your business. |
